110 related articles for article (PubMed ID: 31966899)
1. Differential expression of miR-200c in breast cancer stem cells.
Wu D; Ji N; Zhang L; Zhang L
Int J Clin Exp Pathol; 2017; 10(9):10085-10091. PubMed ID: 31966899
[TBL] [Abstract][Full Text] [Related]
2. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
3. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF
Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells.
Chen SM; Wang BY; Lee CH; Lee HT; Li JJ; Hong GC; Hung YC; Chien PJ; Chang CY; Hsu LS; Chang WW
Oncotarget; 2017 Sep; 8(44):76057-76068. PubMed ID: 29100291
[TBL] [Abstract][Full Text] [Related]
7. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
8. miR-200c inhibits breast cancer proliferation by targeting KRAS.
Song C; Liu LZ; Pei XQ; Liu X; Yang L; Ye F; Xie X; Chen J; Tang H; Xie X
Oncotarget; 2015 Oct; 6(33):34968-78. PubMed ID: 26392416
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.
Zhang H; Sun Z; Li Y; Fan D; Jiang H
Biomed Pharmacother; 2017 Apr; 88():285-292. PubMed ID: 28113080
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
12. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells.
Qiu M; Liang Z; Chen L; Tan G; Liu L; Wang K; Chen H; Liu J
Exp Ther Med; 2017 Apr; 13(4):1329-1336. PubMed ID: 28413473
[TBL] [Abstract][Full Text] [Related]
14. Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals.
Liu J; Shen JX; He D; Zhang GJ
Mol Imaging Biol; 2018 Oct; 20(5):761-770. PubMed ID: 29532351
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer.
Rahimi M; Sharifi-Zarchi A; Zarghami N; Geranpayeh L; Ebrahimi M; Alizadeh E
Cell J; 2020 Jan; 21(4):467-478. PubMed ID: 31376329
[TBL] [Abstract][Full Text] [Related]
16. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.
Mei J; Wang DH; Wang LL; Chen Q; Pan LL; Xia L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):623-631. PubMed ID: 29461619
[TBL] [Abstract][Full Text] [Related]
18. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
20. EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c.
Xu L; Lin J; Deng W; Luo W; Huang Y; Liu CQ; Zhang FP; Qin YF; Wong PP; Liu C
Oncogenesis; 2020 Nov; 9(11):101. PubMed ID: 33168810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
